Clinical Lab Products
VerifiedMagazine
Clinical Lab Products’ mission is to act as the product-related interface to clinical lab professionals, providing product news and introductions as well as editorial features that showcase breakthrough technologies and help improve testing and diagnostic procedures. In a competitive marketplace, no other lab-oriented franchise maintains an exclusive focus on issues related to the development, adoption, and implementation of products and services intended for use in regulated clinical laboratories. Suppliers of such products benefit from placement in editorial contexts defined by Clinical Lab Products to meet the needs and interests of clinical laboratory professionals. Source
Actions
Media Outlet details
| Scope | International, Trade/B2B |
|---|---|
| Language | English |
| Country | United States of America |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
| Frequency | Monthly |
Recent Articles
Search ArticlesLigoLab Reports AI and Automation Takeaways from LigoVerse 2026 Conference
Laboratory leaders gathered in Los Angeles to discuss practical applications of artificial intelligence and workflow automation in clinical lab operations. LigoLab, a laboratory informatics company based in Glendale, California, has reported key findings from LigoVerse 2026, a two-day conference held in Hollywood, Los Angeles, focused on the role of artificial intelligence (AI) and automation in clinical laboratory operations.
Clarapath Releases Updated Robotic Microtomy Platform for Clinical Histology Labs
The latest version of SectionStar was developed with histotechnologists to address staffing pressures and rising case volumes in anatomic pathology. Clarapath has launched the latest release of its SectionStar platform, a Food and Drug Administration (FDA)-registered robotic microtomy system designed to improve consistency, efficiency, and quality control in clinical histology workflows. The updated platform is now being deployed at select laboratory sites across the country.
Biotium’s New Cell Barcoding Kit Allows Up to 15-Sample Multiplexing in a Single Flow Cytometry Tube
The ViaPlex 2-Color Cell Barcoding Kit uses two reactive fluorescent dyes to combine up to 15 distinct cell populations in one tube, reducing reagent use and run time. Biotium has released the ViaPlex 2-Color Cell Barcoding Kit, a fluorescent cell barcoding tool that allows researchers to label and pool up to 15 distinct cell populations into a single tube for multiplex flow cytometry analysis, according to a release from the Fremont, CA-based company.
New England Biolabs Opens Applications for 2026 Passion in Science Awards
The awards recognize scientists for contributions in mentorship, humanitarian service, environmental stewardship, and creativity. New England Biolabs (NEB) is now accepting entries for the 2026 Passion in Science Awards. The program recognizes members of the scientific community who demonstrate a commitment to scientific mentorship, humanitarian service, environmental stewardship, and artistic or creative spirit.
CellCarta Secures Exclusive Global Rights to Deploy Aspyre Lung Assay in Lung Cancer Clinical Trials
The partnership is designed to streamline targeted genomic testing for sponsors running biomarker-driven lung cancer trials. CellCarta and Biofidelity have announced an expanded multi-year global strategic partnership that grants CellCarta exclusive rights to deploy Biofidelity’s Aspyre Lung assay in clinical trial settings worldwide.
Seed Funding to Advance Biopsy Catchment Technology and Liquid Specimen Biorepository
A $4 million financing round will support development of a liquid specimen biorepository and expand biopsy catchment pilot programs at medical institutions across the US. Virchow Medical has closed a $4 million seed financing round led by Cerberus Ventures to advance its biopsy specimen stewardship technologies and expand access to precision oncology diagnostics. Chenny Zhang, managing director for Cerberus Ventures, will join the Virchow Board of Directors as part of the deal.
Biocartis Earns European Certification for Colorectal Cancer Companion Diagnostic Test
The Idylla CDx MSI Test detects microsatellite instability in colorectal cancer tissue in under three hours, supporting therapy selection for eligible patients. Biocartis has received Class C companion diagnostic (CDx) certification under the European Union’s In Vitro Diagnostic Medical Device Regulation (IVDR) for its Idylla CDx MSI Test, the company announced.
Clinical Trial to Evaluate Finger-Prick Blood Test for Alzheimer’s Diagnosis
The study will analyze three key proteins to determine if blood-based biomarkers can provide an earlier and more accessible diagnostic method. Re:Cognition Health is delivering an international clinical trial to evaluate whether a finger-prick blood test can improve how Alzheimer’s disease is diagnosed. Compared with current invasive and expensive diagnostic methods, this approach aims to provide a scalable solution for an earlier, more accurate, and affordable diagnostic method.
Labcorp’s FDA-Cleared Rapid Fentanyl Urine Test Launches
The test detects norfentanyl to identify exposure in acute care settings and is designed for use in CLIA-certified laboratories. Labcorb has launched its Food and Drug Administration (FDA)-cleared rapid fentanyl urine test that provides results in 10 minutes. The test is designed to help healthcare providers identify suspected fentanyl exposure in emergency departments, hospitals, and clinics. The Labcorp Fentanyl Urine Visual Test detects norfentanyl, the primary metabolite of fentanyl.
ViewsML to Present Virtual Staining Research at AACR 2026
The AI-powered platform provides biomarker insights from standard pathology slides without the need for traditional laboratory staining. ViewsML will present research on its virtual immunohistochemistry (vIHC) at the American Association for Cancer Research (AACR) Annual Meeting, which takes place April 17-22, 2026, in San Diego, CA. The company will highlight how its platform uses to provide biomarker insights from a single hematoxylin and eosin (H&E) slide, according to a press release.